Blaine Davis

Insider Reports History

Location
New York, NY
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Blaine Davis
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Blaine Davis:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. Chief Financial Officer Common Stock 121,220 $826,684 $6.82 06 Jan 2026 Direct
Protara Therapeutics, Inc. Chief Financial Officer Common Stock 20,662 $39,464 $1.91 15 Jul 2022 Direct
Cartesian Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 109,000 02 Jan 2026 Direct
Protara Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 84,800 03 Jan 2022 Direct

Insider Reports Filed by Blaine Davis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAC Cartesian Therapeutics, Inc. 06 Jan 2026 1 -$72,227 4 Chief Financial Officer 08 Jan 2026, 16:19
RNAC Cartesian Therapeutics, Inc. 02 Jan 2026 2 $0 4 Chief Financial Officer 06 Jan 2026, 16:18
RNAC Cartesian Therapeutics, Inc. 03 Jan 2025 2 -$134,036 4 Chief Financial Officer 07 Jan 2025, 20:04
RNAC Cartesian Therapeutics, Inc. 02 Jan 2025 2 $0 4 Chief Financial Officer 06 Jan 2025, 16:20
RNAC Cartesian Therapeutics, Inc. 02 Jan 2024 2 $0 4 Chief Financial Officer 04 Jan 2024, 17:08
RNAC Cartesian Therapeutics, Inc. 13 Nov 2023 1 -$987,500 4 Chief Financial Officer 15 Nov 2023, 17:26
RNAC SELECTA BIOSCIENCES INC 28 Nov 2022 1 $0 4 Chief Financial Officer 30 Nov 2022, 15:40
RNAC SELECTA BIOSCIENCES INC 28 Nov 2022 0 $0 3 Chief Financial Officer 30 Nov 2022, 15:37
TARA Protara Therapeutics, Inc. 15 Jul 2022 1 -$15,904 4 Chief Financial Officer 19 Jul 2022, 16:31
TARA Protara Therapeutics, Inc. 03 Jan 2022 2 $0 4 Chief Financial Officer 05 Jan 2022, 15:35